Atopic Dermatitis Clinical Trials

• Have chronic atopic dermatitis (AD) (according to American Academy of Dermatology Consensus Criteria) that has been present for ≥1 year before screening visit.

• Have 10% to 25% body surface area (BSA) of AD involvement at screening and baseline.

• Have pruritus numeric rating scale (NRS) ≥6 at baseline.

• Have an Eczema Area and Severity Index (EASI) score ≥16 at screening and baseline.

• Have an Investigator's Global Assessment (IGA) score ≥3 (on a scale of 0 to 4) at screening and baseline.

• Based on investigator judgement, have a history of inadequate response to treatment with topical medications, or determination that topical treatments are otherwise medically inadvisable.

• For participants aged 12 to less than 18, have a body weight ≥40 kilograms (kg) at baseline.